2/5
07:08 am
imcr
VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors
Low
Report
VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors
2/4
08:43 am
imcr
Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
2/4
04:52 am
imcr
Levicept Announces the Appointment of James Sandy as Chief Development Officer [Yahoo! Finance]
Low
Report
Levicept Announces the Appointment of James Sandy as Chief Development Officer [Yahoo! Finance]
2/4
04:00 am
imcr
Levicept Announces the Appointment of James Sandy as Chief Development Officer
Low
Report
Levicept Announces the Appointment of James Sandy as Chief Development Officer
2/2
04:52 am
imcr
Assessing Immunocore Holdings (IMCR) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Low
Report
Assessing Immunocore Holdings (IMCR) Valuation After Recent Share Price Volatility [Yahoo! Finance]
2/1
07:53 am
imcr
Moderna Refocuses On Rare Diseases As New Leadership Shapes Pipeline [Yahoo! Finance]
Low
Report
Moderna Refocuses On Rare Diseases As New Leadership Shapes Pipeline [Yahoo! Finance]
1/31
01:33 am
imcr
1/30
09:21 am
imcr
Moderna CMO Jacqueline Miller to step down [Yahoo! Finance]
Low
Report
Moderna CMO Jacqueline Miller to step down [Yahoo! Finance]
1/30
07:00 am
imcr
Immunocore announces R&D leadership evolution
Low
Report
Immunocore announces R&D leadership evolution
1/24
05:08 am
imcr
Immunocore (NASDAQ:IMCR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Immunocore (NASDAQ:IMCR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
1/19
11:45 am
imcr
JPM26: Immunocore Signals Entry into Type 1 Diabetes [Yahoo! Finance]
Low
Report
JPM26: Immunocore Signals Entry into Type 1 Diabetes [Yahoo! Finance]
1/10
10:56 am
imcr
How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets [Yahoo! Finance]
Low
Report
How The Narrative Around Immunocore Holdings (IMCR) Is Shifting With New Data And Street Targets [Yahoo! Finance]
1/9
07:41 am
imcr
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/9
07:00 am
imcr
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
1/9
06:10 am
imcr
Immunocore (NASDAQ:IMCR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Immunocore (NASDAQ:IMCR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/8
06:15 am
imcr
Immunocore (NASDAQ:IMCR) was upgraded by analysts at UBS Group AG from a "strong sell" rating to a "strong-buy" rating.
Medium
Report
Immunocore (NASDAQ:IMCR) was upgraded by analysts at UBS Group AG from a "strong sell" rating to a "strong-buy" rating.
1/7
04:06 am
imcr
Immunocore (NASDAQ:IMCR) was given a new $55.00 price target on by analysts at UBS Group AG.
Low
Report
Immunocore (NASDAQ:IMCR) was given a new $55.00 price target on by analysts at UBS Group AG.
12/9
12:27 am
imcr
Immunocore Holdings plc (IMCR) Asserts Pipeline Development and Strong Commercial Performance [Yahoo! Finance]
Medium
Report
Immunocore Holdings plc (IMCR) Asserts Pipeline Development and Strong Commercial Performance [Yahoo! Finance]
11/27
06:40 pm
imcr
Immunocore (IMCR) Q2 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Immunocore (IMCR) Q2 2025 Earnings Call Transcript [Yahoo! Finance]
11/18
09:00 am
imcr
The Galien Foundation Announces 2025 Prix Galien Bridges Awards Nominees for "Best Bridge-Builder Institution," "Best Biomedical Product," "Best Medical Technology/AI Advances in Human Health," "Best Product for Rare/Orphan Diseases," and "Best Public Sec
Low
Report
The Galien Foundation Announces 2025 Prix Galien Bridges Awards Nominees for "Best Bridge-Builder Institution," "Best Biomedical Product," "Best Medical Technology/AI Advances in Human Health," "Best Product for Rare/Orphan Diseases," and "Best Public Sec